Company page

Bioarctic Ab Class B

Bioarctic Ab Class B is a public company listed in Sweden under the ticker BIOA_B, with a market capitalization of approximately 3.24 billion SEK. The company focuses on developing innovative treatments for neurodegenerative diseases. Bioarctic is committed to advancing its research and product pipeline to address significant medical needs in this area.